Related Experiment Video
Updated: Apr 10, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Segmented filamentous bacteria are associated with disease activity in children with inflammatory bowel disease
Yuling Feng1, Huahai Chen2, Yeshi Yin3
1Department of Digestive Endoscopy Center, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Insights
Segmented filamentous bacteria (SFB) are more prevalent in children with inflammatory bowel disease (IBD), particularly during active disease stages. SFB presence correlates with increased disease severity and inflammation markers in pediatric IBD patients.
Area of Science:
- Microbiology
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- Inflammatory Bowel Disease (IBD) in children is a complex condition with multifactorial etiologies.
- Segmented filamentous bacteria (SFB) have been implicated in gut inflammation, but their role in pediatric IBD requires further investigation.
Purpose of the Study:
- To determine the positivity rate of SFB in pediatric patients diagnosed with IBD.
- To assess the association between SFB presence and the activity and severity of pediatric IBD.
Main Methods:
- A cross-sectional study involving 30 pediatric IBD patients and 30 controls with functional gastrointestinal disorders.
- SFB detection in terminal ileum lavage fluid using polymerase chain reaction (PCR).
- Stratification of IBD patients by disease activity (Untreated Active, Treated Remission, Treated Active) and type (Crohn's disease, ulcerative colitis).
Main Results:
- SFB positivity was significantly higher in pediatric IBD patients (63.3%) compared to controls (36.7%).
- The Untreated Active (UTA) IBD subgroup exhibited the highest SFB positivity rate (82.4%), significantly elevated compared to controls and the Treated Remission (TRR) group.
- SFB-positive patients demonstrated significantly higher disease activity indices and elevated inflammatory markers (fecal calprotectin, CRP, ESR) than SFB-negative patients.
Conclusions:
- SFB positivity is more frequent in pediatric IBD patients, especially those with active disease.
- The presence of SFB is associated with increased inflammatory activity and disease severity in pediatric IBD.
- Findings suggest SFB may play a role in the pathogenesis or exacerbation of pediatric IBD.
Objectives:
This study aimed to determine the positivity rate of segmented filamentous bacteria (SFB) in pediatric patients with inflammatory bowel disease (IBD) and to evaluate its association with disease activity.
Methods:
In this cross-sectional study, 30 pediatric IBD patients and 30 children with functional gastrointestinal disorders were enrolled. SFB in ileal lavage fluid from the terminal ileum were detected using polymerase chain reaction. IBD patients were stratified according to treatment status and disease activity-Untreated Active (UTA), Treated Remission (TRR), Treated Active (TRA)-as well as by disease type (Crohn's disease or ulcerative colitis). SFB positivity rates were compared across subgroups. Within the IBD cohort, disease activity and inflammatory markers, including fecal calprotectin, C-reactive protein, erythrocyte sedimentation rate, platelets count, were compared between SFB-positive and SFB-negative patients.
Results:
The SFB positivity rate was significantly higher in pediatric IBD patients than in controls (63.3% vs. 36.7%, P = 0.038). Subgroup analysis showed that the UTA group had the highest SFB positivity rate (82.4%), which was significantly higher than both the control group (P = 0.002) and the TRR group (28.6%, P = 0.021). Among TRA group, the SFB positivity rate remained elevated (50.0%). The positive rate did not differ significantly from that of the UTA group (P > 0.05). The SFB positivity rate was higher in pediatric Crohn's disease patients (66.7%, 14/21) than in controls but showed no significant difference compared with ulcerative colitis (P > 0.05). SFB-positive patients exhibited significantly higher disease activity indices (PCDAI, P = 0.005; PUCAI, P = 0.021) and elevated inflammatory markers (fecal calprotectin, P = 0.001; C-reactive protein, P = 0.001; erythrocyte sedimentation rate, P = 0.001) compare with SFB-negative patients.
Conclusions:
SFB positivity occurred more frequently in pediatric IBD than in controls-especially in active disease-and was associated with higher inflammatory activity and disease severity.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Bacterial Gastroenteritis
Bacterial Phylum Actinobacteria
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cytoskeletal Proteins in Bacteria